The University of Kansas Cancer Center

https://www.kucancercenter.org/

 

Videos
13:17

Insights from 2024 EHA Annual Meeting

EHA 2024 Insights: Golcadomide, an Oral CELMoD, + R-CHOP in Patients With Untreated Aggressive B-Cell Lymphoma

FEATURING Marc Hoffmann
  • 32 views
  • July 18, 2024
12:21

Insights from 2023 SABCS

SABCS 2023 Insights: "How to Treat TNBC"

FEATURING Priyanka Sharma
  • 593 views
  • January 22, 2024
  • 4
09:24

The University of Kansas Cancer Center

Treatment Sequence in mTNBC

FEATURING Priyanka Sharma
  • 441 views
  • July 14, 2023
  • 3
07:47

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "The X-7/7 Randomized Trial - Fixed Dose Capecitabine Compared to Standard Dose Capecitabine in mBC"

FEATURING Colleen Bohnenkamp
  • 362 views
  • June 16, 2023
  • 2
14:05

The University of Kansas Cancer Center

Five-Year Updates on Venetoclax + Obinutuzumab for Previously Untreated CLL: Clinical Learnings From the CLL14 Study

FEATURING Marc Hoffmann
  • 540 views
  • February 1, 2023
  • 4
13:40

SABCS 2021 Conference Coverage on VuMedi

Optimizing Use of HER2 Therapies in MBC

FEATURING Priyanka Sharma
  • 194 views
  • January 25, 2022
10:44

The University of Kansas Cancer Center

Phase II DREAMM-2: Belantamab Mafodotin in R/R MM

FEATURING Al-Ola Abdallah
  • 349 views
  • July 23, 2021
07:59

The University of Kansas Cancer Center

2021 ASCO Updates From LIMBER-313 on Myelofibrosis: Parsaclisib + Ruxolitinib for JAKi/PI3Ki Treatment-Naïve Patients

FEATURING Abdulraheem Yacoub
  • 40 views
  • June 29, 2021
08:58

The University of Kansas Cancer Center

ASCO 2021 Update on mTNBC: Considering Outcomes With Romidepsin / Cisplatin / Nivolumab Triplet Combination

FEATURING Priyanka Sharma
  • 362 views
  • June 14, 2021
  • 1
11:45

The University of Kansas Cancer Center

2021 Updates on MF: Addition of Parsaclisib in Patients With Suboptimal Response to Ruxolitinib

FEATURING Abdulraheem Yacoub
  • 53 views
  • May 19, 2021
06:08

The University of Kansas Cancer Center

2020 Update on PARPi/Chemo Option in mTNBC: How Effective Is the Addition of Veliparib to Cisplatin?

FEATURING Priyanka Sharma
  • 126 views
  • October 5, 2020
  • 1